S&P 500   4,574.79
DOW   35,756.88
QQQ   379.12
S&P 500   4,574.79
DOW   35,756.88
QQQ   379.12
S&P 500   4,574.79
DOW   35,756.88
QQQ   379.12
S&P 500   4,574.79
DOW   35,756.88
QQQ   379.12

Compare Stocks

Date Range: 

 OraSure TechnologiesPAVmedSI-BONESurmodicsOrthofix Medical
SymbolNASDAQ:OSURNASDAQ:PAVMNASDAQ:SIBNNASDAQ:SRDXNASDAQ:OFIX
Price Information
Current Price$10.61$5.85$21.42$55.37$35.77
50-Day Moving Average$11.01$7.60$22.59$56.07$39.66
52-Week Low$8.58$1.63$19.26$35.17$30.58
52-Week High$16.17$9.70$37.21$62.27$48.50
MarketRank™
Overall Score2.32.22.22.51.5
Analysis Score3.33.53.53.50.0
Community Score4.84.54.54.54.1
Dividend Score0.00.00.00.00.0
Ownership Score1.72.52.52.51.7
Earnings & Valuation Score1.90.60.61.91.9
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyN/A
Consensus Price Target$15.83$7.50$37.67$73.00N/A
% Upside from Price Target49.23% upside28.21% upside75.85% upside31.84% upsideN/A
Trade Information
Market Cap$764.02 million$495.89 million$712.67 million$768.09 million$704.49 million
Beta-0.280.311.41.021.13
Average Volume933,0763,031,055315,74444,92385,272
Sales & Book Value
Annual Revenue$171.72 millionN/A$73.39 million$94.86 million$406.56 million
Price / Sales4.45N/A9.718.101.73
CashflowN/AN/AN/A$0.65 per share$1.78 per share
Price / CashN/AN/AN/A85.1120.04
Book Value$5.56 per share($0.04) per share$5.23 per share$9.63 per share$18.37 per share
Price / Book1.91N/A4.105.751.95
Profitability
Net Income$-14.92 million$-34.28 million$-43.70 million$1.12 million$2.52 million
EPS($0.22)($0.43)($1.50)$0.13$0.26
Trailing P/E Ratio151.57N/AN/A553.76N/A
Forward P/E Ratio50.52N/AN/A38.1928.85
P/E GrowthN/AN/AN/A25.80N/A
Net Margins2.34%N/A-52.47%1.52%-1.78%
Return on Equity (ROE)1.33%-144.36%-30.43%3.03%6.82%
Return on Assets (ROA)1.17%-72.46%-22.32%2.41%4.73%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A0.26N/A0.06
Current Ratio6.128.6915.775.333.17
Quick Ratio5.098.6915.134.972.17
Ownership Information
Institutional Ownership Percentage88.63%24.81%92.97%89.80%95.68%
Insider Ownership Percentage1.70%14.10%7.00%7.10%4.00%
Miscellaneous
Employees570252953701,036
Shares Outstanding72.01 million84.77 million33.27 million13.87 million19.70 million
Next Earnings Date11/3/2021 (Estimated)11/16/2021 (Estimated)11/8/2021 (Confirmed)11/3/2021 (Estimated)11/4/2021 (Estimated)
OptionableOptionableNot OptionableNot OptionableOptionableOptionable
SourceHeadline
The Artificial Disc Replacement Market To Reach A Befitting US$ 1,300 Million From 2019 to 2029The Artificial Disc Replacement Market To Reach A Befitting US$ 1,300 Million From 2019 to 2029
openpr.com - October 25 at 12:36 PM
$112.90 Million in Sales Expected for Orthofix Medical Inc. (NASDAQ:OFIX) This Quarter$112.90 Million in Sales Expected for Orthofix Medical Inc. (NASDAQ:OFIX) This Quarter
americanbankingnews.com - October 25 at 2:50 AM
Zacks: Analysts Expect Orthofix Medical Inc. (NASDAQ:OFIX) to Announce $0.07 EPSZacks: Analysts Expect Orthofix Medical Inc. (NASDAQ:OFIX) to Announce $0.07 EPS
americanbankingnews.com - October 23 at 1:16 PM
Medical Bionic Implant Market to Witness a Pronounce Growth during 2025Medical Bionic Implant Market to Witness a Pronounce Growth during 2025
openpr.com - October 21 at 11:36 PM
Insurers Accuse Orthofix of Running a ‘Prosthetic Mafia’Insurers Accuse Orthofix of Running a ‘Prosthetic Mafia’
courthousenews.com - October 21 at 11:36 PM
China Spinal Fusion Market to Double its Global Share by 2025 | Future Market InsightsChina Spinal Fusion Market to Double its Global Share by 2025 | Future Market Insights
pharmiweb.com - October 18 at 8:46 AM
Insights on the External Fixators Global Market to 2026 - Featuring Acumed, Aptis Medical and Integra LifeSciences Among OthersInsights on the External Fixators Global Market to 2026 - Featuring Acumed, Aptis Medical and Integra LifeSciences Among Others
nz.finance.yahoo.com - October 12 at 8:54 AM
Orthofix Medical Names Finance Exec to BODOrthofix Medical Names Finance Exec to BOD
ryortho.com - October 7 at 8:46 AM
Zacks: Analysts Anticipate Orthofix Medical Inc. (NASDAQ:OFIX) Will Post Quarterly Sales of $112.90 MillionZacks: Analysts Anticipate Orthofix Medical Inc. (NASDAQ:OFIX) Will Post Quarterly Sales of $112.90 Million
americanbankingnews.com - October 6 at 2:28 PM
Biosurgery Market worth $16.0 Billion by 2026: Growing Adoption of Advanced Biosurgery Products in Emerging MarketsBiosurgery Market worth $16.0 Billion by 2026: Growing Adoption of Advanced Biosurgery Products in Emerging Markets
benzinga.com - October 1 at 1:22 AM
Orthofix Expects Low-single Digit Revenue Growth In Q3Orthofix Expects Low-single Digit Revenue Growth In Q3
nasdaq.com - September 29 at 7:17 PM
Orthofix Provides Business UpdateOrthofix Provides Business Update
finance.yahoo.com - September 29 at 7:17 PM
Medical device maker Orthofix warns that Q3 revenue will rise only in low-single digits as COVID delays proceduresMedical device maker Orthofix warns that Q3 revenue will rise only in low-single digits as COVID delays procedures
finance.yahoo.com - September 29 at 7:17 PM
Orthofix Announces Milestone − More Than 60,000 M6-C Artificial Cervical Discs Implanted WorldwideOrthofix Announces Milestone − More Than 60,000 M6-C Artificial Cervical Discs Implanted Worldwide
finance.yahoo.com - September 27 at 9:33 AM
Orthofix Announces Appointment of Wayne Burris to Board of DirectorsOrthofix Announces Appointment of Wayne Burris to Board of Directors
finance.yahoo.com - September 23 at 9:34 AM
Orthofix Announces Full Market Launch of Opus Mg Set – a Magnesium-based Settable Bone Void Filler for Orthopedic ProceduresOrthofix Announces Full Market Launch of Opus Mg Set – a Magnesium-based Settable Bone Void Filler for Orthopedic Procedures
finance.yahoo.com - September 22 at 12:42 AM
Devicemaker launches bone void filler for orthopedic surgeriesDevicemaker launches bone void filler for orthopedic surgeries
beckersspine.com - September 21 at 7:41 PM
Press Release: Orthofix Announces Participation in Upcoming Sidoti Virtual Investor ConferencePress Release: Orthofix Announces Participation in Upcoming Sidoti Virtual Investor Conference
sharecast.com - September 20 at 7:25 AM
Orthofix Announces Participation in Upcoming Sidoti Virtual Investor ConferenceOrthofix Announces Participation in Upcoming Sidoti Virtual Investor Conference
finance.yahoo.com - September 20 at 7:25 AM
Medical Bionic Implants Market is Expected to Grow Drastically, Assured By Experts From 2021 To 2027Medical Bionic Implants Market is Expected to Grow Drastically, Assured By Experts From 2021 To 2027
globalbankingandfinance.com - September 18 at 5:45 PM
Bone Growth Stimulation Devices Market 2021 | Growth Drivers Challenges, Trends and Industry Dynamics, Forecast 2028Bone Growth Stimulation Devices Market 2021 | Growth Drivers Challenges, Trends and Industry Dynamics, Forecast 2028
pharmiweb.com - September 10 at 2:30 AM
Orthofix Medicals Return on Invested Capital InsightsOrthofix Medical's Return on Invested Capital Insights
benzinga.com - September 9 at 4:10 PM
Orthofix (OFIX) Fitbone Used in 1st US Pediatric Patient ImplantOrthofix (OFIX) Fitbone Used in 1st US Pediatric Patient Implant
finance.yahoo.com - September 2 at 5:21 PM
Zimmer Biomets smart knee implant, Aurora Spines Q2 results & more: 7 device company notesZimmer Biomet's smart knee implant, Aurora Spine's Q2 results & more: 7 device company notes
beckersspine.com - September 1 at 5:17 PM
Orthofix Announces First US Pediatric Implant of the Fitbone Limb-Lengthening SystemOrthofix Announces First US Pediatric Implant of the Fitbone Limb-Lengthening System
finance.yahoo.com - September 1 at 7:11 AM
DateCompanyBrokerageAction
9/30/2021SI-BONETruist Securities
Lower Price Target
9/30/2021SI-BONETruist
Lower Price Target
9/22/2021OraSure TechnologiesRaymond James
Downgrade
9/20/2021OraSure TechnologiesLake Street Capital
Boost Price Target
9/8/2021SurmodicsNeedham & Company LLC
Boost Price Target
8/13/2021PAVmedMaxim Group
Reiterated Rating
8/4/2021OraSure TechnologiesRaymond James
Boost Price Target
8/4/2021OraSure TechnologiesLake Street Capital
Lower Price Target
8/4/2021OraSure TechnologiesCitigroup
Boost Price Target
8/3/2021SI-BONEMorgan Stanley
Lower Price Target
8/3/2021SI-BONENeedham & Company LLC
Reiterated Rating
7/9/2021PAVmedCantor Fitzgerald
Reiterated Rating
6/28/2021OraSure TechnologiesRaymond James
Lower Price Target
6/8/2021SI-BONECitigroup
Initiated Coverage
6/4/2021PAVmedMaxim Group
Reiterated Rating
5/6/2021OraSure TechnologiesLake Street Capital
Lower Price Target
5/6/2021OraSure TechnologiesRaymond James
Lower Price Target
5/4/2021SI-BONETruist Securities
Boost Price Target
5/4/2021SI-BONETruist
Boost Price Target
5/4/2021SI-BONECanaccord Genuity
Boost Price Target
5/4/2021SI-BONENeedham & Company LLC
Boost Price Target
5/4/2021SI-BONEMorgan Stanley
Boost Price Target
4/19/2021SI-BONEMorgan Stanley
Boost Price Target
3/29/2021PAVmedCantor Fitzgerald
Initiated Coverage
3/9/2021SI-BONEMorgan Stanley
Boost Price Target
3/9/2021SI-BONENeedham & Company LLC
Lower Price Target
3/2/2021OraSure TechnologiesCitigroup
Lower Price Target
2/22/2021PAVmedLake Street Capital
Boost Price Target
2/10/2021SurmodicsBarrington Research
Boost Price Target
2/5/2021SurmodicsNeedham & Company LLC
Reiterated Rating
2/1/2021SI-BONENeedham & Company LLC
Reiterated Rating
1/8/2021SI-BONEJMP Securities
Boost Price Target
12/17/2020SI-BONECanaccord Genuity
Boost Price Target
12/16/2020SI-BONENeedham & Company LLC
Boost Price Target
12/15/2020SI-BONEMorgan Stanley
Boost Price Target
11/5/2020PAVmedAscendiant Capital Markets
Initiated Coverage
10/20/2020Orthofix MedicalStifel Nicolaus
Initiated Coverage
10/13/2020PAVmedLake Street Capital
Initiated Coverage
9/30/2020SI-BONEJMP Securities
Boost Price Target
8/21/2020OraSure TechnologiesEvercore ISI
Initiated Coverage
8/10/2020OraSure TechnologiesCitigroup
Initiated Coverage
8/10/2020OraSure TechnologiesJPMorgan Chase & Co.
Initiated Coverage
8/7/2020OraSure TechnologiesRaymond James
Upgrade
8/6/2020SurmodicsBarrington Research
Reiterated Rating
8/4/2020SI-BONEMorgan Stanley
Boost Price Target
8/4/2020SI-BONECanaccord Genuity
Reiterated Rating
8/4/2020SI-BONENeedham & Company LLC
Boost Price Target
7/23/2020SurmodicsNeedham & Company LLC
Upgrade
6/25/2020OraSure TechnologiesLake Street Capital
Initiated Coverage
6/15/2020SI-BONECantor Fitzgerald
Initiated Coverage
6/10/2020SurmodicsBarrington Research
Reiterated Rating
6/8/2020SI-BONECantor Fitzgerald
Reiterated Rating
6/1/2020SurmodicsLake Street Capital
Boost Price Target
5/30/2020PAVmedMaxim Group
Reiterated Rating
5/29/2020SI-BONENeedham & Company LLC
Reiterated Rating
5/22/2020PAVmedMaxim Group
Reiterated Rating
4/30/2020SurmodicsBarrington Research
Reiterated Rating
4/30/2020SurmodicsNeedham & Company LLC
Reiterated Rating
4/21/2020OraSure TechnologiesStephens
Initiated Coverage
4/17/2020PAVmedMaxim Group
Reiterated Rating
2/26/2020PAVmedMaxim Group
Reiterated Rating
2/25/2020Orthofix MedicalSidoti
Lower Price Target
2/25/2020Orthofix MedicalCantor Fitzgerald
Lower Price Target
2/6/2020SurmodicsBarrington Research
Reiterated Rating
2/6/2020SurmodicsLake Street Capital
Upgrade
2/6/2020SurmodicsNeedham & Company LLC
Downgrade
12/11/2019SurmodicsNeedham & Company LLC
Downgrade
11/22/2019PAVmedMaxim Group
Reiterated Rating
11/11/2019OraSure TechnologiesCanaccord Genuity
Reiterated Rating
11/1/2019SurmodicsBarrington Research
Reiterated Rating
11/1/2019SurmodicsLake Street Capital
Downgrade
10/29/2019Orthofix MedicalCantor Fitzgerald
Downgrade
8/16/2019PAVmedMaxim Group
Set Price Target
8/14/2019OraSure TechnologiesCanaccord Genuity
Reiterated Rating
8/1/2019SurmodicsNeedham & Company LLC
Reiterated Rating
5/23/2019PAVmedMaxim Group
Reiterated Rating
5/9/2019OraSure TechnologiesCanaccord Genuity
Downgrade
5/2/2019SurmodicsBarrington Research
Set Price Target
5/2/2019SurmodicsLake Street Capital
Set Price Target
5/2/2019SurmodicsNeedham & Company LLC
Reiterated Rating
4/7/2019PAVmedMaxim Group
Reiterated Rating
2/26/2019Orthofix MedicalBTIG Research
Reiterated Rating
2/21/2019SurmodicsNeedham & Company LLC
Reiterated Rating
2/7/2019OraSure TechnologiesCanaccord Genuity
Reiterated Rating
1/31/2019SurmodicsNeedham & Company LLC
Reiterated Rating
1/18/2019Orthofix MedicalCantor Fitzgerald
Set Price Target
1/14/2019PAVmedMaxim Group
Reiterated Rating
1/8/2019Orthofix MedicalCantor Fitzgerald
Set Price Target
11/9/2018SurmodicsNeedham & Company LLC
Reiterated Rating
(Data available from 10/27/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.